Explore 100+ time-tested natural remedies in Nature's Armor 2025 - a digital guidebook designed to support immunity, reduce stress, and promote everyday wellness with safe, accessible solutions.
Read More
Aspire's sublingual aspirin formulation significantly inhibited serum thromboxane B2 (TxB2) within the first two minutes after dosing
TxB2 is a biomarker indicating aspirin's effect on platelet aggregation, the clumping of platelets that leads to dangerous blood clots
This rapid inhibition is critical during suspected heart attacks, when clots blocking heart arteries can cause permanent muscle damage
Lab results showed Aspire's product acted approximately twice as fast as the current recommendation for chewed aspirin tablet treatment
These clinical trial results enable a potential regulatory submission for accelerated approval on track for Q3 2025
American Robotics to showcase Iron Drone Raider at international INTERPOL Drone Incursion Countermeasure Exercise (IDICE) organized by UAS Norway in cooperation with INTERPOL
Participation highlights Ondas' leadership in advancing counter-UAS capabilities for global defense and homeland security markets
Read More